Dynamic changes in HCV RNA levels and viral quasispecies in a patient with chronic hepatitis C after telaprevir-based treatment
Authors:
- Joep de BruijneJBJoep de Bruijne
- James C. SullivanJSJames C. Sullivan
- Tara L. KiefferTKTara L. Kieffer
- Martyn BotfieldMBMartyn Botfield
- Ben ShamesBSBen Shames
- Janke SchinkelJSJanke Schinkel
- Richard MolenkampRMRichard Molenkamp
- Christine WeeginkCWChristine Weegink
- Henk ReesinkHRHenk Reesink
- 1 February 2012
- journal article
- case report
- Published by Elsevier in Journal of Clinical Virology
- Vol. 53 (2) , 174-177
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Telaprevir for Previously Treated Chronic HCV InfectionNew England Journal of Medicine, 2010
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C InfectionNew England Journal of Medicine, 2009
- Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV InfectionNew England Journal of Medicine, 2009
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2009
- Long-Term Course of Chronic Hepatitis C in Children: From Viral Clearance to End-Stage Liver DiseaseGastroenterology, 2008
- Chronic Hepatitis C: Viral Clearance Several Months after Discontinuation of Therapy in Two Non-respondersInfection, 2007
- Rapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized StudyGastroenterology, 2006
- Combination of a Hepatitis C Virus NS3-NS4A Protease Inhibitor and Alpha Interferon Synergistically Inhibits Viral RNA Replication and Facilitates Viral RNA Clearance in Replicon CellsAntimicrobial Agents and Chemotherapy, 2004
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 2001
- Hepatitis C Virus InfectionNew England Journal of Medicine, 2001